Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair Loss
NCT ID: NCT05943860
Last Updated: 2023-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
39 participants
INTERVENTIONAL
2021-09-13
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss
NCT01900041
Nutraceutical Supplement With Vegan Botanicals in Females With Self-Perceived Thinning Hair
NCT05332743
Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females
NCT06376409
ENERGI-F701 for Female Hair Loss Treatment
NCT03351322
Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and Men
NCT06362941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pantovigar vegan treatment
Pantovigar® vegan
Oral application of 1 capsule three times a day (morning, noon, evening) for 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pantovigar® vegan
Oral application of 1 capsule three times a day (morning, noon, evening) for 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Modified Savin Score I to III
* Hair length of at least 2 cm
Exclusion Criteria
* Symptomatic diffuse alopecia due to pathological low iron concentration or thyroid gland disorder
* Acute telogen effluvium
* Recent or concomitant treatment with any drugs that may cause hair loss
* Concomitant diseases that can cause hair loss
30 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merz Therapeutics GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Merz Medical Expert
Role: STUDY_DIRECTOR
Merz Therapeutics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
proDerm
Schenefeld, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M900411001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.